NCT06892639View on ClinicalTrials.gov

Evaluation of D-Fi for the Treatment of Wounds Due to DEB

PHASE3RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 27, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

February 28, 2042

Conditions
Dystrophic Epidermolysis Bullosa
Interventions
BIOLOGICAL

D-Fi

D-Fi is composed of fibroblasts isolated from the subject's skin biopsies which are genetically corrected with the full length COL7A1 gene encoding for type VII collagen.

Trial Locations (4)

80045

RECRUITING

Children's Hospital Colorado, Aurora

92688

RECRUITING

Mission Dermatology, Santa Margarita

94063

RECRUITING

Stanford University School of Medicine, Dermatology, Redwood City

01655

RECRUITING

University of Massachusetts, Worcester

Sponsors
All Listed Sponsors
collaborator

Prosoft Clinical

OTHER

lead

Castle Creek Biosciences, LLC.

INDUSTRY